International Clinical Trial: Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07134478) titled 'Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects' on Aug. 14.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Haisco Pharmaceutical Group Co., Ltd.

Condition: Healthy Subjects

Intervention: Drug: HSK31858 Tablets On the morning of Day 1, a single dose of HSK31858 tablets 40 mg will be administered. Rifampicin capsules After a 5-day washout period, a single dose of rifampicin capsules 600 mg wi...

Recruitment Status: Not recrui...